Overview Topiramate 25 mg Capsules Under Fed Conditions Status: Completed Trial end date: 2002-07-01 Target enrollment: Participant gender: Summary The objective of this study was to compare the rate and extent of absorption of topiramate 25 mg capsules (test) versus Topamax® (reference) administered as 2 25 mg capsules under fed conditions. Phase: Phase 1 Details Lead Sponsor: Teva Pharmaceuticals USATreatments: Topiramate